Manifestation of a cancer-associated TIF-1 gamma dermatomyositis after COVID-19 vaccine.
作者信息
Ooi Xue Ting, Choi Ellie Ce, Lee Joyce Ss
机构信息
Division of Dermatology, University Medicine Cluster, National University Hospital, Singapore.
Dermatology, National Skin Centre, Singapore.
出版信息
Int J Dermatol. 2022 Nov;61(11):1425-1426. doi: 10.1111/ijd.16358. Epub 2022 Jul 14.
Abstract
摘要
相似文献
1
Manifestation of a cancer-associated TIF-1 gamma dermatomyositis after COVID-19 vaccine.新冠疫苗接种后癌症相关的TIF-1γ皮肌炎表现
Int J Dermatol. 2022 Nov;61(11):1425-1426. doi: 10.1111/ijd.16358. Epub 2022 Jul 14.
2
A case of Anti-MDA5-Positive dermatomyositis after inactivated COVID-19 vaccine.1例新型冠状病毒灭活疫苗接种后抗MDA5阳性皮肌炎病例。
J Eur Acad Dermatol Venereol. 2023 Feb;37(2):e127-e129. doi: 10.1111/jdv.18653. Epub 2022 Oct 31.
3
Appearance of anti-MDA5 antibody-positive dermatomyositis after COVID-19 vaccination.新冠病毒疫苗接种后抗MDA5抗体阳性皮肌炎的出现。
Mod Rheumatol Case Rep. 2023 Jan 3;7(1):108-112. doi: 10.1093/mrcr/rxac064.
4
Dermatomyositis with anti-TIF-1γ antibodies as a presenting symptom of underlying triple-negative breast cancer: a case report.以抗TIF-1γ抗体为首发症状的皮肌炎作为三阴性乳腺癌的潜在表现：一例报告
BMC Cancer. 2016 Aug 25;16(1):684. doi: 10.1186/s12885-016-2715-1.
5
Disease flare in patients with dermatomyositis following COVID-19 vaccination.新冠病毒疫苗接种后皮肌炎患者的疾病复发
J Am Acad Dermatol. 2022 Dec;87(6):1373-1374. doi: 10.1016/j.jaad.2022.07.010. Epub 2022 Jul 9.
6
Vaccine-induced dermatomyositis following COVID-19 vaccination.新冠病毒疫苗接种后引发的疫苗诱导性皮肌炎
Dermatol Ther. 2022 Oct;35(10):e15749. doi: 10.1111/dth.15749. Epub 2022 Aug 18.
7
Antimelanoma Differentiation-Associated Gene 5 Antibody-Positive Interstitial Lung Disease After Vaccination With COVID-19 mRNA Vaccines.抗黑色素瘤分化相关基因 5 抗体阳性间质性肺病与 COVID-19 mRNA 疫苗接种后。
J Rheumatol. 2022 Oct;49(10):1158-1162. doi: 10.3899/jrheum.220259. Epub 2022 Jun 15.
8
Dermatomyositis following COVID-19 vaccination.新型冠状病毒肺炎疫苗接种后发生的皮肌炎
Dermatol Ther. 2022 Jun;35(6):e15479. doi: 10.1111/dth.15479. Epub 2022 Apr 7.
9
Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy.抗转录中介因子-1β抗体作为一种肌炎特异性抗体：与临床无肌病性皮肌炎或伴轻度肌病的皮肌炎的临床相关性。
Br J Dermatol. 2019 Apr;180(4):881-887. doi: 10.1111/bjd.17098. Epub 2018 Oct 10.
10
Use of Anti-transcriptional Intermediary Factor-1 Gamma Autoantibody in Identifying Adult Dermatomyositis Patients with Cancer: A Systematic Review and Meta-analysis.抗转录中介因子-1γ 自身抗体在识别伴癌成人皮肌炎患者中的应用：系统评价和荟萃分析。
Acta Derm Venereol. 2019 Mar 1;99(3):256-262. doi: 10.2340/00015555-3091.
引用本文的文献
1
Anti-MDA5 autoantibodies predict clinical dynamics of dermatomyositis following SARS-CoV-2 mRNA vaccination: a retrospective statistical analysis of case reports.抗 MDA5 自身抗体预测 SARS-CoV-2 mRNA 疫苗接种后皮肌炎的临床动态：病例报告的回顾性统计分析。
Rheumatol Int. 2024 Oct;44(10):2185-2196. doi: 10.1007/s00296-024-05683-5. Epub 2024 Aug 27.
2
Inflammatory myopathy following coronavirus disease 2019 vaccination: A systematic review.新型冠状病毒病 2019 疫苗接种后的炎症性肌病：系统评价。
Front Public Health. 2022 Oct 21;10:1007637. doi: 10.3389/fpubh.2022.1007637. eCollection 2022.
本文引用的文献
1
Two cases of anti-TIF1-γ antibody positive dermatomyositis with manifested symptoms after SARS-CoV-19 vaccination.两例接种SARS-CoV-19疫苗后出现症状的抗TIF1-γ抗体阳性皮肌炎病例。
J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e517-e520. doi: 10.1111/jdv.18060. Epub 2022 Mar 17.
2
Recurrent erythema nodosum after the second dose of the Pfizer-BioNTech BNT162b2 COVID-19 messenger RNA vaccine.第二剂辉瑞-BioNTech BNT162b2新冠信使核糖核酸疫苗接种后复发性结节性红斑
JAAD Int. 2022 Mar;6:107-108. doi: 10.1016/j.jdin.2021.12.009. Epub 2021 Dec 28.
3
Cutaneous findings following COVID-19 vaccination: review of world literature and own experience.接种 COVID-19 疫苗后的皮肤表现：世界文献复习和自身经验。
J Eur Acad Dermatol Venereol. 2022 Feb;36(2):172-180. doi: 10.1111/jdv.17744. Epub 2021 Nov 2.
4
Dermatomyositis: Clinical features and pathogenesis.皮肌炎：临床特征与发病机制。
J Am Acad Dermatol. 2020 Feb;82(2):267-281. doi: 10.1016/j.jaad.2019.06.1309. Epub 2019 Jul 4.
Zotero 插件